{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.","slug":"late-stage-development-and-commercial-planning-with-cervomed-s-matt-winton-ph-d","published_at":"2026-07-20T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/late-stage-development-and-commercial-planning-with-cervomed-s-matt-winton-ph-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19497426-late-stage-development-and-commercial-planning-with-cervomed-s-matt-winton-ph-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19497426-late-stage-development-and-commercial-planning-with-cervomed-s-matt-winton-ph-d.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Business Officer at CervoMed, talks about preparing for the late-stage development of neflamapimod in dementia with Lewy bodies (DLB) and commercial planning for an anticipated launch. Winton talks about CMC and manufacturing scale-up, partnership, communicating with regulators and the benefits of global regulatory alignment on protocols for the P...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Busines…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3387,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/late-stage-development-and-commercial-planning-with-cervomed-s-matt-winton-ph-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/late-stage-development-and-commercial-planning-with-cervomed-s-matt-winton-ph-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}